Cargando…
Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease affecting the upper and lower motor neurons, leading to muscle weakness, motor impairments, disabilities and death. Approximately 5–10% of ALS cases are associated with positive family history (familial ALS or fALS), whils...
Autores principales: | Bagyinszky, Eva, Hulme, John, An, Seong Soo A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417729/ https://www.ncbi.nlm.nih.gov/pubmed/37566027 http://dx.doi.org/10.3390/cells12151948 |
Ejemplares similares
-
Gene Therapy in Amyotrophic Lateral Sclerosis
por: Fang, Ton, et al.
Publicado: (2022) -
Progress in Therapy Development for Amyotrophic Lateral Sclerosis
por: Venkova-Hristova, Kalina, et al.
Publicado: (2012) -
Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy
por: Wang, Hui, et al.
Publicado: (2023) -
Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
por: Kirk, Siobhan E., et al.
Publicado: (2019) -
Functional Biomarkers for Amyotrophic Lateral Sclerosis
por: Huynh, William, et al.
Publicado: (2019)